Keyphrases
Overall Survival
100%
Chemoradiotherapy
100%
Radiotherapy Alone
100%
Survival Outcomes
100%
Upper Tract Urothelial Carcinoma
100%
HGT1
100%
Non-muscle Invasive Bladder Cancer (NMIBC)
50%
Hazard Ratio
33%
Multivariable
33%
Bladder Cancer
33%
Confidence Interval
16%
Lamina Propria
16%
Kaplan-Meier Method
16%
Clinical Course
16%
Cox Regression
16%
Randomized Clinical Trial
16%
Regression Modeling
16%
Comparative Effectiveness
16%
Combined Modality Therapy
16%
Log-rank Test
16%
National Cancer Database
16%
Retrospective Cohort
16%
Inverse Probability of Treatment Weighting
16%
Transurethral Resection of Bladder Tumor (TURBT)
16%
Bladder Preservation
16%
Preservation Strategy
16%
Medicine and Dentistry
Overall Survival
100%
Bladder
100%
Radiation Therapy
100%
Chemoradiotherapy
100%
Transitional Cell Carcinoma
100%
Non Muscle Invasive Bladder Cancer
50%
Hazard Ratio
33%
Bladder Cancer
33%
Malignant Neoplasm
16%
Proportional Hazards Model
16%
Kaplan Meier Method
16%
Disease Course
16%
Randomized Clinical Trial
16%
Transurethral Resection
16%
Bladder Tumor
16%
Log Rank Test
16%
Lamina Propria
16%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
100%
Chemoradiation Therapy
100%
Transitional Cell Carcinoma
100%
Non Muscle Invasive Bladder Cancer
50%
Bladder Cancer
33%
Malignant Neoplasm
16%
Randomized Clinical Trial
16%
Disease Course
16%
Bladder Tumor
16%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Lamina Propria
16%
Randomized Clinical Trial
16%